Table 4.
References | Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | Item 9 | Item 10 | Quality |
---|---|---|---|---|---|---|---|---|---|---|---|
Adeyemi et al. (18) |
Yes | Yes | Yes | Yes | No | No | No | Yes | Unclear | No | Moderate |
Klassen et al. (38) |
Yes | Yes | Yes | Yes | No | Yes | No | No | Unclear | Yes | Moderate |
Mikula et al. (39) |
Yes | Yes | No | No | No | No | No | No | Unclear | Yes | Moderate |
Flauzino et al. (40) |
Yes | No | No | Yes | No | Yes | No | Yes | Unclear | No | Moderate |
Paul et al. (41) |
Yes | Yes | No | Unclear | No | No | No | Yes | Unclear | No | Moderate |
Ross et al. (29) |
Yes | Yes | Yes | Unclear | No | Yes | No | Yes | Unclear | No | Moderate |
Thuppal et al. (30) |
Yes | Yes | Yes | Unclear | No | Yes | No | Yes | Unclear | No | Moderate |
Ceballos et al. (37) |
Yes | Yes | Yes | Unclear | No | No | No | Yes | Unclear | No | Moderate |
Hidron et al. (32) |
Yes | No | Yes | Yes | No | No | No | Yes | Unclear | No | Moderate |
The 10 evaluation items are as follows:
Item 1 Define the source of information (survey, record review).
Item 2 List the inclusion and exclusion criteria for exposed and unexposed subjects (cases and controls) or refer to previous publications.
Item 3 Indicate the time period used for identifying patients.
Item 4 Indicate whether or not the subjects were consecutive, if not population-based.
Item 5 Indicate if the evaluators of the subjective components of the study were masked to other aspects of the status of the participants.
Item 6 Describe any assessments undertaken for quality assurance purposes (e.g., test/retest of primary outcome measurements).
Item 7 Explain the exclusion of any patient from the analysis.
Item 8 Describe how confounding variables were assessed and/or controlled.
Item 9 If applicable, explain how missing data were handled in the analysis.
Item 10 Summarize the patient response rates and completeness of the data collection.